1. Programmed cell death: the battlefield between the host and alpha-herpesviruses and a potential avenue for cancer treatment
   Chuankuo Zhao et al, 2018, Oncotarget CrossRef
2. Oncolytic bovine herpesvirus type 1 as a broad spectrum cancer therapeutic
   Breanne P Cuddington et al, 2015, Current Opinion in Virology CrossRef
3. Oncolytic viruses: A novel treatment strategy for breast cancer
   Mohammad Javanbakht et al, 2023, Genes & Diseases CrossRef
4. Triple‐mutated oncolytic herpes virus for treating both fast‐ and slow‐growing tumors
   Hiroshi Fukuhara et al, 2021, Cancer Science CrossRef
5. Recent Developments and Anticancer Therapeutics of Paclitaxel: An Update
   Muthu Thiruvengadam et al, 2022, Current Pharmaceutical Design CrossRef
6. Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma
   Breanne P Cuddington et al, 2015, Molecular Therapy - Oncolytics CrossRef
7. The oncolytic herpes simplex virus vector, G47Δ, effectively targets tamoxifen-resistant breast cancer cells
   JINGJING FAN et al, 2016, Oncology Reports CrossRef
8. Inhibition of the Aurora A kinase augments the anti-tumor efficacy of oncolytic measles virotherapy
   I D Iankov et al, 2015, Cancer Gene Therapy CrossRef
9. Combination strategies enhance oncolytic virotherapy
   Gregory K. Friedman et al, 2017, Oncotarget CrossRef
10. Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
    Bart Spiesschaert et al, 2021, Cancers CrossRef
11. Oncolytic viruses for triple negative breast cancer and beyond
    Shengye Jin et al, 2021, Biomarker Research CrossRef
12. Therapeutic potency of oncolytic virotherapy in breast cancer targeting, current status and perspective
    Safieh Ebrahimi et al, 2019, Journal of Cellular Biochemistry CrossRef
13. Virotherapy: From single agents to combinatorial treatments
    Anna Maria Malfitano et al, 2020, Biochemical Pharmacology CrossRef
14. Novel delivery approaches for cancer therapeutics
    Ashim K. Mitra et al, 2015, Journal of Controlled Release CrossRef
15. Trial Watch:
    Jonathan Pol et al, 2014, OncoImmunology CrossRef
16. Treatment of Human Thyroid Carcinoma Cells with the G47delta Oncolytic Herpes Simplex Virus
    Jia-Ni Wang et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
17. The role of viruses in cancer development versus cancer therapy: An oncological perspective
    Hossein Javid et al, 2023, Cancer Medicine CrossRef
18. Chemovirotherapy of Pancreatic Adenocarcinoma by Combining Oncolytic Vaccinia Virus GLV-1h68 with nab -Paclitaxel Plus Gemcitabine
    Eike Binz et al, 2017, Molecular Therapy - Oncolytics CrossRef
19. Microbial Therapy and Breast Cancer Management: Exploring Mechanisms, Clinical Efficacy, and Integration within the One Health Approach
    Charalampos Filippou et al, 2024, International Journal of Molecular Sciences CrossRef
20. Fusion peptide is superior to co-expressing subunits for arming oncolytic herpes virus with interleukin 12
    Hiroshi Fukuhara et al, 2023, Communications Medicine CrossRef